[Theopek in the treatment of patients with obstructive diseases of the respiratory organs].
Data are reported on the high clinical and broncholytic efficacy of a new native preparation of theophylline of prolonged action--theopek. The drug is well tolerated by the patients, reduces the necessity in broncholytics and glucocorticosteroids and is recommended for basis therapy of patients with obstructive diseases of the respiratory organs.
Korzh
O B
OB
Vygovskiĭ
V P
VP
Stadnicheko
R A
RA
Borzhievskaia
O E
OE
Kopel'man
E I
EI
Kozak
K M
KM
Senyk
R V
RV
Vygovskiĭ
Ia V
IaV
D000328:Adult; D000368:Aged; D001249:Asthma / Q000188:drug therapy; D001991:Bronchitis / Q000188:drug therapy; D002908:Chronic Disease; D003692:Delayed-Action Preparations; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012140:Respiratory Tract Diseases / Q000188:drug therapy*; D013806:Theophylline / Q000009:adverse effects / Q000627:therapeutic use*; D013997:Time Factors
D003692:Delayed-Action Preparations; D013806:Theophylline
Teopék v lechenii bol'nykh obstruktivnymi zabolevaniiami organov dykhaniia.